Baird Financial Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2M Buy
142,953
+9,704
+7% +$865K 0.02% 513
2025
Q4
$10.5M Sell
133,249
-14,468
-10% -$1.13M 0.02% 523
2025
Q3
$11.8M Sell
147,717
-1,555
-1% -$133K 0.02% 497
2025
Q2
$13.6M Sell
149,272
-15,457
-9% -$1.41M 0.02% 455
2025
Q1
$15.4M Sell
164,729
-1,960
-1% -$176K 0.03% 413
2024
Q4
$15.2M Sell
166,689
-1,165
-0.7% -$111K 0.03% 406
2024
Q3
$17.4M Buy
167,854
+782
+0.5% +$79.7K 0.03% 376
2024
Q2
$16.2M Buy
167,072
+1,823
+1% +$168K 0.03% 370
2024
Q1
$14.9M Sell
165,249
-7,788
-5% -$660K 0.03% 393
2023
Q4
$13.8M Buy
173,037
+3,749
+2% +$282K 0.03% 395
2023
Q3
$12M Sell
169,288
-150,530
-47% -$11.3M 0.03% 393
2023
Q2
$24.6M Buy
319,818
+7,974
+3% +$617K 0.07% 261
2023
Q1
$23.4M Buy
311,844
+6,305
+2% +$469K 0.06% 277
2022
Q4
$24.1M Buy
305,539
+10,202
+3% +$765K 0.06% 274
2022
Q3
$20.7M Sell
295,337
-10,693
-3% -$838K 0.06% 282
2022
Q2
$24.5M Buy
306,030
+11,468
+4% +$897K 0.07% 269
2022
Q1
$22.3M Sell
294,562
-3,942
-1% -$312K 0.06% 295
2021
Q4
$25.5M Buy
298,504
+7,234
+2% +$565K 0.06% 276
2021
Q3
$22M Buy
291,270
+18,888
+7% +$1.5M 0.06% 278
2021
Q2
$22.2M Buy
272,382
+4,377
+2% +$358K 0.06% 287
2021
Q1
$21.1M Sell
268,005
-4,744
-2% -$372K 0.06% 286
2020
Q4
$23.3M Buy
272,749
+1,887
+0.7% +$156K 0.07% 261
2020
Q3
$20.9M Buy
270,862
+10,007
+4% +$763K 0.07% 260
2020
Q2
$19.1M Buy
260,855
+593
+0.2% +$42.1K 0.07% 250
2020
Q1
$17.3M Sell
260,262
-4,715
-2% -$333K 0.08% 243
2019
Q4
$18.2M Sell
264,977
-9,671
-4% -$659K 0.07% 273
2019
Q3
$20.2M Sell
274,648
-10,084
-4% -$732K 0.08% 251
2019
Q2
$20.4M Buy
284,732
+134,310
+89% +$9.53M 0.08% 257
2019
Q1
$10.3M Sell
150,422
-711
-0.5% -$45.9K 0.06% 315
2018
Q4
$8.99M Buy
151,133
+106,683
+240% +$6.67M 0.06% 310
2018
Q3
$2.98M Buy
44,450
+3,726
+9% +$248K 0.02% 572
2018
Q2
$2.64M Sell
40,724
-1,846
-4% -$121K 0.02% 588
2018
Q1
$3.05M Buy
42,570
+8,745
+26% +$629K 0.02% 529
2017
Q4
$2.55M Buy
33,825
+338
+1% +$24.7K 0.02% 559
2017
Q3
$2.44M Sell
33,487
-18,905
-36% -$1.36M 0.02% 571
2017
Q2
$3.88M Buy
52,392
+7,214
+16% +$536K 0.03% 455
2017
Q1
$3.31M Buy
45,178
+13,560
+43% +$949K 0.03% 480
2016
Q4
$2.07M Sell
31,618
-1,115
-3% -$76.5K 0.02% 565
2016
Q3
$2.43M Sell
32,733
-3,106
-9% -$230K 0.02% 518
2016
Q2
$2.63M Buy
35,839
+784
+2% +$55.8K 0.02% 494
2016
Q1
$2.48M Sell
35,055
-25,027
-42% -$1.67M 0.02% 488
2015
Q4
$4M Buy
60,082
+620
+1% +$41.2K 0.04% 390
2015
Q3
$3.77M Sell
59,462
-15,835
-21% -$1.03M 0.04% 384
2015
Q2
$4.92M Buy
+75,297
New +$5.11M 0.05% 342

Other funds holding CL

Baird Financial Group's CL Position: Q1 2026 in Review

Baird Financial Group increased its Colgate-Palmolive (CL) stake by 7.3% in Q1 2026, buying an estimated $865K and bringing the position to 142,953 shares worth $12.2M. The position accounts for 0.02% of the portfolio, ranked #513.

Baird Financial Group first reported a position in CL in Q2 2015 and has held it in 44 quarters since. The position peaked at $25.5M in Q4 2021. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Baird Financial Group held 142,953 shares of Colgate-Palmolive worth $12.2M as of Q1 2026.
  • Baird Financial Group bought 9,704 Colgate-Palmolive shares in Q1 2026, an estimated $865K.
  • Colgate-Palmolive made up 0.02% of Baird Financial Group's portfolio in Q1 2026, its #513 holding.
  • Baird Financial Group first reported a position in Colgate-Palmolive in Q2 2015 and has held it in 44 quarters since.
  • Baird Financial Group's Colgate-Palmolive position peaked at $25.5M in Q4 2021.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.